Development of a new model of viral hemorrhagic fever.

病毒性出血热新模型的开发。

基本信息

  • 批准号:
    7241848
  • 负责人:
  • 金额:
    $ 18.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-30 至 2009-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infection of macaque monkeys with simian hemorrhagic fever virus (SHFV) causes a rapid onset, fatal hemorrhagic disease. In contrast, species of African monkeys, such as patas monkeys, African green monkeys and baboons, develop asymptomatic acute or persistent SHFV infections. High levels of viremia have been documented in persistently infected patas monkeys. Macaques inoculated with the blood of long term persistently infected patas monkeys rapidly develop hemorrhagic disease. SHFV is a BSL2 level agent which does not infect humans. The ultimate goal of this project is to develop a BSL2 animal model of viral hemorrhagic fever which can be used for the development and testing of "generic" countermeasures of hemorrhagic disease. The hemorrhagic disease caused by SHFV in macaques is very similar to that caused by other BSL4 hemorrhagic fever viruses such as Ebola Zaire virus. The dramatic difference in disease outcome observed between macaques and African monkeys, even though SHFV replicates efficiently in both types of animals provides a unique system for dissecting the viral and host factors involved in triggering hemorrhagic disease. The construction and testing of a reverse genetic system for SHFV is proposed. This system will be used to begin the study of viral proteins involved in triggering host cell responses. Since essentially nothing is currently known about the cellular response to SHFV, comparative studies of SHFV replication in monocyte, macrophage and dendritic cell cultures from disease resistant and disease susceptible monkeys is proposed. Cell responses to SHFV will be assayed by a variety of methods. Proinflamnmtory cytokine production, tissue factor cell surface expression and gene expression patterns will be analyzed. This study will provide preliminary insights about the cellular factors/pathways and viral proteins that trigger or prevent a hemorrhagic response to SHFV infection and will provide reagents needed for further development of this model. The long term goal of this project is the development of a new BSL2 model of viral hemorrhagic fever that will be valuable for testing novel "generic" therapies for the treatment of hemorrhagic disease. Viral reagents needed for the further development of this model will be generated and preliminary comparative studies of the initial responses to simian hemorrhagic fever virus in cells from disease resistant and susceptible monkeys will provide further insights into the mechanisms involved in triggering viral hemorrhagic disease.
描述(由申请人提供):猕猴感染猴出血热病毒(SHFV)会导致快速发病,致命的出血性疾病。相比之下,非洲猴子物种,如斑猴、非洲绿猴和狒狒,会出现无症状的急性或持续性SHFV感染。高水平的病毒血症已被记录在持续感染的猴身上。用长期持续感染的猴血接种的猕猴迅速发展为出血性疾病。SHFV是一种BSL2水平的病原体,不会感染人类。该项目的最终目标是开发一种BSL2型病毒性出血热动物模型,可用于开发和测试出血性疾病的“通用”对策。由SHFV引起的猕猴出血性疾病与其他BSL4型出血热病毒如埃博拉扎伊尔病毒引起的出血性疾病非常相似。尽管SHFV在两种动物中都能有效复制,但在猕猴和非洲猴之间观察到的疾病结果的巨大差异为解剖引发出血性疾病的病毒和宿主因素提供了一个独特的系统。提出了一个SHFV反向遗传系统的构建和测试。该系统将用于开始研究参与触发宿主细胞反应的病毒蛋白。由于目前对SHFV的细胞反应基本上一无所知,因此提出了在抗病和易感猴子的单核细胞、巨噬细胞和树突状细胞培养物中进行SHFV复制的比较研究。细胞对SHFV的反应将通过多种方法进行检测。将分析促炎细胞因子的产生、组织因子细胞表面表达和基因表达模式。该研究将提供关于触发或阻止SHFV感染出血反应的细胞因子/途径和病毒蛋白的初步见解,并将为该模型的进一步开发提供所需的试剂。该项目的长期目标是开发一种新的病毒性出血热BSL2模型,这将对测试治疗出血性疾病的新型“通用”疗法有价值。进一步开发该模型所需的病毒试剂将被生成,并且对来自疾病抗性和易感猴的细胞对猴出血热病毒的初始反应进行初步比较研究,将为引发病毒性出血病的机制提供进一步的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margo A Brinton其他文献

Margo A Brinton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margo A Brinton', 18)}}的其他基金

Project 4 - Inhibitors of Flavivirus Replication
项目 4 - 黄病毒复制抑制剂
  • 批准号:
    10513945
  • 财政年份:
    2022
  • 资助金额:
    $ 18.06万
  • 项目类别:
Alternative regulation of ISGs in WNV-infected cells
WNV 感染细胞中 ISG 的替代调节
  • 批准号:
    8500175
  • 财政年份:
    2012
  • 资助金额:
    $ 18.06万
  • 项目类别:
Alternative regulation of ISGs in WNV-infected cells
WNV 感染细胞中 ISG 的替代调节
  • 批准号:
    8385421
  • 财政年份:
    2012
  • 资助金额:
    $ 18.06万
  • 项目类别:
Functional analysis of flavivirus genetic resistance.
黄病毒遗传抗性的功能分析。
  • 批准号:
    8068144
  • 财政年份:
    2010
  • 资助金额:
    $ 18.06万
  • 项目类别:
Development of a new model of viral hemorrhagic fever.
病毒性出血热新模型的开发。
  • 批准号:
    7501890
  • 财政年份:
    2007
  • 资助金额:
    $ 18.06万
  • 项目类别:
Analysis of SNPs Associated With WNV-Induced Disease
与西尼罗河病毒引起的疾病相关的 SNP 分析
  • 批准号:
    6912093
  • 财政年份:
    2004
  • 资助金额:
    $ 18.06万
  • 项目类别:
Analysis of SNPs Associated With WNV-Induced Disease
与西尼罗河病毒引起的疾病相关的 SNP 分析
  • 批准号:
    7119237
  • 财政年份:
    2004
  • 资助金额:
    $ 18.06万
  • 项目类别:
Oas-1 gene transgenic mice for WNV research.
用于 WNV 研究的 Oas-1 基因转基因小鼠。
  • 批准号:
    6876512
  • 财政年份:
    2004
  • 资助金额:
    $ 18.06万
  • 项目类别:
Oas-1 gene transgenic mice for WNV research.
用于 WNV 研究的 Oas-1 基因转基因小鼠。
  • 批准号:
    6758238
  • 财政年份:
    2004
  • 资助金额:
    $ 18.06万
  • 项目类别:
Analysis of SNPs Associated With WNV-Induced Disease
与西尼罗河病毒引起的疾病相关的 SNP 分析
  • 批准号:
    6953145
  • 财政年份:
    2004
  • 资助金额:
    $ 18.06万
  • 项目类别:

相似海外基金

Tracing the African roots of Sri-Lanka Portuguese
追溯斯里兰卡葡萄牙语的非洲根源
  • 批准号:
    AH/Z505717/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Research Grant
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Research Grant
Commercialisation of African Youth Enterprise Programme
非洲青年企业计划商业化
  • 批准号:
    ES/Y010752/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Research Grant
Resilient and Equitable Nature-based Pathways in Southern African Rangelands (REPAiR)
南部非洲牧场弹性且公平的基于自然的途径 (REPAiR)
  • 批准号:
    NE/Z503459/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Research Grant
Evaluating the effectiveness and sustainability of integrating helminth control with seasonal malaria chemoprevention in West African children
评估西非儿童蠕虫控制与季节性疟疾化学预防相结合的有效性和可持续性
  • 批准号:
    MR/X023133/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Fellowship
Understanding differences in host responses to African swine fever virus
了解宿主对非洲猪瘟病毒反应的差异
  • 批准号:
    BB/Z514457/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Fellowship
The impact on human health of restoring degraded African drylands
恢复退化的非洲旱地对人类健康的影响
  • 批准号:
    MR/Y019806/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Research Grant
CAREER: Habitability of the Hadean Earth - A South African perspective
职业:冥古宙地球的宜居性——南非的视角
  • 批准号:
    2336044
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Continuing Grant
Nowcasting with Artificial Intelligence for African Rainfall: NAIAR
利用人工智能预测非洲降雨量:NAIAR
  • 批准号:
    NE/Y000420/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Research Grant
South African Modernism (Follow-on-Funding): Decolonising English Literary Studies In and Beyond the Classroom
南非现代主义(后续资助):课堂内外的英国文学研究去殖民化
  • 批准号:
    AH/Z50581X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.06万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了